People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Other Technology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | — | Pharmaceuticals | Series C | $192.5M | $611.8M | 2012 |
| Vicept Therapeutics, Inc. | — | Pharmaceuticals | Series B | $22.0M | $536.9M | 2009 |
| Ralexar Therapeutics, Inc. | — | Pharmaceuticals | Series A | $19.0M | $132.5M | 2014 |
| Myota, Inc. | — | Other Technology | Series A | $15.7M | $8.9M | 2018 |
| Active Protective Technologies, Inc. | — | Software / Tech | Series A | $14.5M | $245.8M | 2014 |
Neal Walker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Neal Walker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Tullman | 3 | 7 |
| Albert Cha | 2 | 9 |
| ANAND MEHRA | 2 | 7 |
| Kamil Ali-Jackson | 2 | 3 |
| Christopher Powala | 2 | 3 |
| Stephen A. Tullman | 2 | 2 |
| Somu Subramaniam | 1 | 17 |
| James Walker | 1 | 16 |
| Ketan Patel | 1 | 10 |
| David Gordon | 1 | 8 |
| Thomas Beck | 1 | 7 |
| Andrew Schiff | 1 | 5 |
| Somasundaram Subramaniam | 1 | 5 |
| Raju Mohan | 1 | 4 |
| Douglas Gessl | 1 | 4 |
| Jason Hong | 1 | 4 |
| Maxine Gowen | 1 | 4 |
| Andrew A. Schiff | 1 | 3 |
| Joseph Monahan | 1 | 3 |
| James C. Walker | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.